ethyl 1-{N-[(6-chloro-1,3,4,9-tetrahydro-2H-beta-carbolin-2-yl)carbonyl]glycyl}piperidine-4-carboxylate

ethyl 1-{N-[(6-chloro-1,3,4,9-tetrahydro-2H-beta-carbolin-2-yl)carbonyl]glycyl}piperidine-4-carboxylate Struktur
1010929-76-6
CAS-Nr.
1010929-76-6
Englisch Name:
ethyl 1-{N-[(6-chloro-1,3,4,9-tetrahydro-2H-beta-carbolin-2-yl)carbonyl]glycyl}piperidine-4-carboxylate
Synonyma:
ethyl 1-{N-[(6-chloro-1,3,4,9-tetrahydro-2H-beta-carbolin-2-yl)carbonyl]glycyl}piperidine-4-carboxylate;4-Piperidinecarboxylic acid, 1-[2-[[(6-chloro-1,3,4,9-tetrahydro-2H-pyrido[3,4-b]indol-2-yl)carbonyl]amino]acetyl]-, ethyl ester
CBNumber:
CB44028691
Summenformel:
C22H27ClN4O4
Molgewicht:
446.93
MOL-Datei:
1010929-76-6.mol

ethyl 1-{N-[(6-chloro-1,3,4,9-tetrahydro-2H-beta-carbolin-2-yl)carbonyl]glycyl}piperidine-4-carboxylate Eigenschaften

Siedepunkt:
682.7±55.0 °C(Predicted)
Dichte
1.355±0.06 g/cm3(Predicted)
pka
13.10±0.20(Predicted)

Sicherheit

ethyl 1-{N-[(6-chloro-1,3,4,9-tetrahydro-2H-beta-carbolin-2-yl)carbonyl]glycyl}piperidine-4-carboxylate Chemische Eigenschaften,Einsatz,Produktion Methoden

ethyl 1-{N-[(6-chloro-1,3,4,9-tetrahydro-2H-beta-carbolin-2-yl)carbonyl]glycyl}piperidine-4-carboxylate Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


ethyl 1-{N-[(6-chloro-1,3,4,9-tetrahydro-2H-beta-carbolin-2-yl)carbonyl]glycyl}piperidine-4-carboxylate Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 4)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
PHARMEKS Ltd. --
sales@pharmeks.com Finland 6350 50
VITAS-M LABORATORY, LTD. --
Russia 6754 64
Interbioscreen Ltd. --
screen@ibscreen.chg.ru Finland 6178 60
OTAVA chemicals --
north.america@otavachemicals.com Ukraine 6495 72

  • ethyl 1-{N-[(6-chloro-1,3,4,9-tetrahydro-2H-beta-carbolin-2-yl)carbonyl]glycyl}piperidine-4-carboxylate
  • 4-Piperidinecarboxylic acid, 1-[2-[[(6-chloro-1,3,4,9-tetrahydro-2H-pyrido[3,4-b]indol-2-yl)carbonyl]amino]acetyl]-, ethyl ester
  • 1010929-76-6
Copyright 2019 © ChemicalBook. All rights reserved